KIDS

#2575

OrthoPediatrics Corp. Common Stock

19.1700

+12.24%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

+12.24%

Месячное изменение

+7.88%

6-месячное изменение

+12.57%

Годовое изменение

+12.57%

Предыдущее закрытие

17.0800

Open

19.1700

Bid

Ask

Low

19.1700

High

19.1700

Объем

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 320.41 M304.27 M427.73 M438.75 M473.21 M Total liabilities 85.64 M78.91 M49.08 M61.72 M118.64 M Total equity 234.77 M225.37 M378.65 M377.02 M354.57 M Total liabilities & shareholders' equities 320.41 M304.27 M427.73 M438.75 M473.21 M Total debt ————— Net debt —————

OrthoPediatrics Corp

OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.

KIDS

Financials

OrthoPediatrics Corp

Новости

Needham повысил целевую цену акций OrthoPediatrics до $30

Needham raises OrthoPediatrics stock price target to $30 on growth

OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

Meta Goes to Trial in a New Mexico Child Safety Case. Here’s What’s at Stake

FDA одобрило систему кохлеарных имплантов iotaMotion для детей от 4 лет

FDA clears iotaMotion’s cochlear implant system for children from age four

TD Cowen начал покрытие акций OrthoPediatrics с рейтинга "Покупать"

TD Cowen initiates coverage on OrthoPediatrics stock with Buy rating

Meta Seeks to Bar Mentions of Mental Health—and Zuckerberg’s Harvard Past—From Child Safety Trial

OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?

OrthoPediatrics reports record 2025 revenue of $236.1 million

Why Are Grok and X Still Available in App Stores?